Orphan nuclear receptor Nur77 participates in human apolipoprotein A5 gene expression.

Abstract

The orphan nuclear receptor Nur77 (NR4A1) has been reported to play a crucial role in the modulation of diverse metabolic processes in liver. Here, we reported the identification of human apolipoprotein A5 (ApoA5), which implicated in lowering plasma triglyceride levels, as a novel target gene of Nur77. Nur77 induced the human ApoA5 promoter activity. Using 5'-deletion and mutagenesis of human ApoA5 promoter analysis and chromatin immunoprecipitation assays, it was shown that Nur77 directly regulated human ApoA5 gene expression by binding to a Nur77 response element (AAAGGTCA) located in the proximal human ApoA5 promoter region. In addition, we demonstrated that blocking of Nur77 transcriptional activity via overexpression of dominant negative Nur77 suppressed human ApoA5 promoter activity and mRNA expression in human hepatoma cells, HepG2. Taken together, our results demonstrated that Nur77 is a novel regulator of human ApoA5 gene expression and provide a new insight into the role of this orphan nuclear receptor in lipoprotein metabolism and triglyceride homeostasis.

DOI: 10.1016/j.bbrc.2009.12.168

Cite this paper

@article{Song2010OrphanNR, title={Orphan nuclear receptor Nur77 participates in human apolipoprotein A5 gene expression.}, author={Kwang Hoon Song}, journal={Biochemical and biophysical research communications}, year={2010}, volume={392 1}, pages={63-6} }